This Resource provides a set of services designed to enable Center Members to validate the applicability of their laboratory findings to the growth and behavior to the growth and behavior of human and animal tumors in vivo and to test their potential clinical significance. In this way, the Center is actively encouraging the application of modern molecular analytical methods to understanding the pathogenesis, progression and treatment of cancer in the living organism. The services offered to further this increasing interest among investigators in this Center include: 1. Target tissue procurement and validation of the pathological nature of the sample. Samples, matched normal tissue and metastases are available. 2. Access to histopathologically evaluated and selected archived paraffin blockers of tissue from human tumors with known clinical outcome. 3. Laser capture microdissection, enabling microscopically controlled super-specific selection of cells and tissues from human and animal tumors, for molecular analysis. 4. Consultation and training on the best samples and methods to use for molecular analysis of pathological processes. Guidance on microdissection of tissue and normal tissues is also provided. 5. Real-time quantitative PCR analysis of gene expression in extracts from human tissue samples. This is a new service in development, to increase the added value of this Resource to Center members. It complements laser capture microscopy. The Resource has been a high value service for some of the most successful recent grant applications at UCSD Cancer Center. It is essential for the growing set of investigators interested in looked for molecular determinants of tumor virulence in vivo.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA023100-18S1
Application #
6501407
Study Section
Project Start
2001-06-21
Project End
2002-04-30
Budget Start
Budget End
Support Year
18
Fiscal Year
2001
Total Cost
$183,723
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Huang, Justin K; Carlin, Daniel E; Yu, Michael Ku et al. (2018) Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. Cell Syst 6:484-495.e5
Kalyanaraman, Hema; Schwaerzer, Gerburg; Ramdani, Ghania et al. (2018) Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes 67:607-623
Hartman, Sheri J; Marinac, Catherine R; Cadmus-Bertram, Lisa et al. (2018) Sedentary Behaviors and Biomarkers Among Breast Cancer Survivors. J Phys Act Health 15:1-6
Wu, Yan; Tamayo, Pablo; Zhang, Kun (2018) Visualizing and Interpreting Single-Cell Gene Expression Datasets with Similarity Weighted Nonnegative Embedding. Cell Syst 7:656-666.e4
Dow, Michelle; Pyke, Rachel M; Tsui, Brian Y et al. (2018) Integrative genomic analysis of mouse and human hepatocellular carcinoma. Proc Natl Acad Sci U S A 115:E9879-E9888
Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin et al. (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558:301-306
Murzin, Vyacheslav L; Woods, Kaley; Moiseenko, Vitali et al. (2018) 4? plan optimization for cortical-sparing brain radiotherapy. Radiother Oncol 127:128-135
Norton, Jeffrey A; Kim, Teresa; Kim, Joseph et al. (2018) SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors. J Gastrointest Surg 22:32-42
Ikeda, Sadakatsu; Tsigelny, Igor F; Skjevik, Åge A et al. (2018) Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. Oncologist 23:586-593
Buckley, Alexandra R; Ideker, Trey; Carter, Hannah et al. (2018) Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Med 10:69

Showing the most recent 10 out of 862 publications